학술논문

High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Document Type
Article
Source
In Toxicon: X September 2020 7
Subject
Language
ISSN
2590-1710